Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Acute Graft vs. Host Disease With Steroids Plus Daclizumab (Zenapax) or Placebo

NCT00053976 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT00053976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00053976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Acute Graft vs. Host Disease With Steroids Plus Daclizumab (Zenapax) or Placebo
Lead sponsor
Dana-Farber Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2001
Completion date
November 30, 2004
Enrollment
105 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease